Exelixis Inc (EXEL)
34.67
+0.02
(+0.06%)
USD |
NASDAQ |
Nov 21, 11:09
Exelixis Price: 34.67 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 34.57 | 34.81 | 34.25 | 34.65 | 1.758M |
| Nov 19, 2024 | 34.20 | 34.59 | 33.82 | 34.41 | 2.208M |
| Nov 18, 2024 | 34.15 | 34.63 | 34.06 | 34.52 | 1.803M |
| Nov 15, 2024 | 34.98 | 35.14 | 34.06 | 34.45 | 2.868M |
| Nov 14, 2024 | 35.19 | 35.52 | 34.98 | 35.05 | 2.981M |
| Nov 13, 2024 | 36.02 | 36.37 | 35.10 | 35.19 | 2.011M |
| Nov 12, 2024 | 36.34 | 36.49 | 35.81 | 35.85 | 1.667M |
| Nov 11, 2024 | 36.32 | 36.48 | 36.10 | 36.19 | 1.915M |
| Nov 08, 2024 | 35.90 | 36.60 | 35.85 | 36.25 | 2.228M |
| Nov 07, 2024 | 35.38 | 36.17 | 35.26 | 35.80 | 1.765M |
| Nov 06, 2024 | 35.30 | 35.84 | 34.97 | 35.51 | 2.520M |
| Nov 05, 2024 | 34.08 | 35.15 | 34.08 | 34.77 | 2.755M |
| Nov 04, 2024 | 34.12 | 34.65 | 33.76 | 34.29 | 2.604M |
| Nov 01, 2024 | 33.44 | 34.45 | 33.34 | 34.12 | 4.537M |
| Oct 31, 2024 | 32.40 | 33.60 | 32.30 | 33.20 | 4.422M |
| Oct 30, 2024 | 31.40 | 33.32 | 31.18 | 32.44 | 6.738M |
| Oct 29, 2024 | 28.48 | 28.98 | 28.30 | 28.73 | 2.808M |
| Oct 28, 2024 | 28.17 | 28.57 | 28.05 | 28.50 | 2.049M |
| Oct 25, 2024 | 28.34 | 28.34 | 27.86 | 27.87 | 1.016M |
| Oct 24, 2024 | 28.34 | 28.79 | 28.00 | 28.11 | 1.174M |
| Oct 23, 2024 | 28.81 | 28.81 | 28.29 | 28.32 | 1.387M |
| Oct 22, 2024 | 28.59 | 29.03 | 28.38 | 28.83 | 1.709M |
| Oct 21, 2024 | 28.95 | 29.09 | 28.39 | 28.66 | 2.060M |
| Oct 18, 2024 | 29.06 | 29.13 | 28.54 | 28.90 | 2.461M |
| Oct 17, 2024 | 29.51 | 29.75 | 28.88 | 29.06 | 3.125M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
14.46
Minimum
Mar 16 2020
36.25
Maximum
Nov 08 2024
20.96
Average
21.02
Median
Nov 01 2023
Price Benchmarks
| Merck & Co Inc | 98.18 |
| ADMA Biologics Inc | 21.22 |
| Vericel Corp | 57.99 |
| Catalyst Pharmaceuticals Inc | 20.89 |
| Inovio Pharmaceuticals Inc | 4.14 |
Price Related Metrics
| PE Ratio | 22.22 |
| PS Ratio | 5.013 |
| PEG Ratio | 0.0493 |
| Price to Book Value | 4.351 |
| Price to Free Cash Flow | 25.77 |
| Earnings Yield | 4.50% |
| Market Cap | 9.901B |
| PEGY Ratio | 0.0493 |
| Operating PE Ratio | 17.16 |
| Normalized PE Ratio | 19.50 |